On June 27th, Gelunhui reported that Shandong Xinhua Pharmaceutical (000756.SZ) stated on its investor interaction platform that the company currently holds a total of 318 patents, including Aspirin, Ibuprofen, Levodopa, Ethoxzolamide, Triphenyl Bismuth, Matrine, Piroxicam and 26 other top-selling or exclusive varieties. The company is an important global supplier of antipyretic and analgesic drugs.
新华制药(000756.SZ)：是全球解热镇痛类药物重要供应商
Shandong Xinhua Pharmaceutical (000756.SZ) is an important supplier of antipyretic and analgesic drugs globally.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.